September 2012


In this Supplement

Advancing Thoracic Care

Exploring the versatility of the Conformable GORE® TAG® Device in challenging thoracic anatomies.



Download a PDF of this supplement

What Exactly Is Radial Fit?

Adaptable technology is crucial in accommodating a variety of patient needs.

By Alan Lumsden, MD, and Jean Bismuth, MD

Intricacies of Isolated Lesions

With technological developments comes new focus on isolated lesions, but what exactly are they?

By William Jordan, MD, and Mark Farber, MD, FACS

TEVAR for Blunt Aortic Injury

Have newer devices made a difference?

By Benjamin W. Starnes, MD

Endovascular Stenting of Blunt Thoracic Aortic Transection Using the Conformable GORE® TAG® Device

Challenging anatomy has become more feasible to navigate.

By Mo Hamady, MD, FRCR; Elika Kashef, MD, FRCR; and Mike Jenkins, MD, FRCS

Conformable GORE® TAG® Device Exclusion of Severe Descending Thoracic Aortic Traumatic Injury

The utility of a new FDA-approved indication.

By Rodney A. White, MD; Christopher Marrocco, MD; George Kopchok, BS; Irwin Walot, MD; and Carlos E. Donayre, MD

Technical Considerations in the Use of TEVAR in Young Patients With Aortic Aneurysms

Dynamic features of the Conformable GORE® TAG® Device can provide unique advantages in the young patient.

By Jehangir J. Appoo, MDCM

Endovascular Repair of a Traumatic Aortic Tear With the Conformable GORE® TAG® Device

This complex problem has seen improved mortality rates thanks to refined technology.

By Juan Carlos Jimenez, MD, FACS; Sharon C. Kiang, MD; and William J. Quinones-Baldrich, MD

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.